PainChek General Discussion, page-3704

One off outliers won't change my investment strategy. But they do get filed away in the back of my brain to make sure I stay focused on the facts and not the speculation and hype.

And speaking of, I think selling at any point in the next six months is risky. I personally think that the FDA approval is worth 10c to PainChek and I think it is highly likely to be granted without delay (ie new information required or similar problems that RAP faced).

I would kick myself for missing that announcement so unless there is some real malfeasance I'm not selling.